Superfluid DX focuses on the detection of neurodegenerative diseases, especially Alzheimer's Disease, using molecular diagnostics
Superfluid DX focuses on the detection of neurodegenerative diseases, especially Alzheimer's Disease, using molecular diagnostics. The company has developed a platform technology that employs cell-free messenger RNA (cf-mRNA) to identify diseases at early stages. This technology allows for patient assessments and informs treatment options without invasive procedures.